More news articles

Vifor wins European approval for Veltassa

European Commission approves the drug to treat hyperkalaemia

Baricitinib delay casts a pall over Lilly's results update

FDA requests further data that could keep the drug off the market for a couple of years

NICE backs Cancer Drugs Fund support for Roche's Gazyvaro

Lymphoma treatment will be used in conjunction with chemotherapy

BMS wins first US immuno-oncology paediatric licence

FDA gives the green light to expanded use of its melanoma treatment Yervoy

Lilly pays Nektar $150m upfront for phase I autoimmune drug

Will add another $250m if candidate meets development objectives

Silence Therapeutics' Ali Mortazavi appointed chairman of ultromics

Takes up the non-executive role at the AI-focused medical imaging firm

Merck & Co's Remicade biosimilar undercuts its US rivals

Its version will be 35% cheaper than J&J's originator product

CHMP backs three immuno-oncology drugs for solid tumours

Roche, MSD and Merck/Pfizer are all on course for new European approvals later this year

Sanofi and Regeneron win CHMP nod for Dupixent

Atopic dermatitis treatment backed for European approval

Mitsubishi buys Israel's NeuroDerm for $1.1bn

The deal will see it focus on a series of drug-device combinations for Parkinson’s disease, headed by phase III candidate ND0612

Constellation Pharmaceuticals strengthens management team

Appointments include Adrian Senderowicz as chief medical officer

Sanofi and Ablynx sign €2.4bn nanobody deal

The duo will develop immune-mediated inflammatory disease candidates

NDA bolsters its senior team

Hires Eva Lilienberg, Christine Chirdo and Barbara Clendenen

Race to CGRP migraine drug finish line enters the final straight

US regulator keeps Aimovig ahead of competitors including Lilly’s galcanezumab

NICE backs Teva's Cinqaero for severe asthma

Ruling will allow it to compete with GSK's rival IL-5 inhibitor Nucala

IMI aims €130m at medical research's unanswered questions

Targets for the partnership’s latest funding round including Alzheimer’s